Chondrosarcoma, Grade 3 — Trials

Chondrosarcoma, Grade 3 — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04458922	Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma	active not recruiting	Phase 2	27	National Cancer Institute (NCI)NIH	2	Jul 31, 2026	clinicaltrials
NCT04278781	AG-120 in People With IDH1 Mutant Chondrosarcoma	active not recruiting	Phase 2	6	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 23, 2026	clinicaltrials